文献
J-GLOBAL ID:202002283464281402
整理番号:20A2468911
HER2陽性乳癌におけるトラスツズマブベース治療抵抗性の予測および予後バイオマーカーとしてのエキソソームmiR-1246およびmiR-155【JST・京大機械翻訳】
Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer
著者 (8件):
Zhang Zhen
(Laboratory for Molecular Immunology, Institute of Basic Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China)
,
Zhang Luoyan
(Key Lab of Plant Stress Research, College of Life Science, Shandong Normal University, Jinan, Shandong, China)
,
Yu Guoxiang
(Department of Breast and Thyroid Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China)
,
Sun Zhigang
(Department of Breast and Thyroid Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China)
,
Wang Tiantian
(Department of Breast and Thyroid Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China)
,
Tian Xingsong
(Department of Breast and Thyroid Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China)
,
Duan Xuening
(Breast Disease Center, Peking University First Hospital, Beijing, China)
,
Zhang Chi
(Department of Breast and Thyroid Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China)
資料名:
Cancer Chemotherapy and Pharmacology
(Cancer Chemotherapy and Pharmacology)
巻:
86
号:
6
ページ:
761-772
発行年:
2020年
JST資料番号:
W4134A
ISSN:
1432-0843
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)